CD274 and colonic neoplasm: Prior investigations have demonstrated E2’s capacity to suppress PD-L1 expression in immune cells infiltrating tumors and its synergistic effect with anti-PD-L1 antibodies in curtailing the growth of MC38 colon tumors [89, 91].